Senate Rejects Tighter DTC Drug Ad Limits

Share this article:
The U.S. Senate yesterday voted against a proposal that would toughen limits on direct-to-consumer drug ads by requiring advertisers to give equal time to information about side effects and similar drugs.


In a 69-26 vote, the Senate rejected the DTC ad rule changes submitted by Sen. John Edwards, D-NC, as an amendment to the Medicare prescription drug benefit plan currently being considered by Congress.


The new rules would have required DTC drug advertisers to display information about side effects as prominently as they display a drug's benefits. Also, advertisers would have to give equal prominence to information about a drug's effectiveness compared with similar drugs.


The rules would have applied to aural, print and video information in DTC drug ads. In addition, the Food and Drug Administration would have been required to accelerate its reviews of the legality of DTC ads placed by drug companies.


Share this article:

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

More in News

News Byte: Comcast Expanding Global Ad Delivery Through Partnership

News Byte: Comcast Expanding Global Ad Delivery Through ...

Through a partnership with Adstream , Comcast's AdDelivery Service expands its footprint across the globe.

40 Under 40 2014: Nominations Are Now Open!

40 Under 40 2014: Nominations Are Now Open!

It's time to nominate the 2014 crop of young marketing luminaries for Direct Marketing News's 40 Under 40 Awards. The deadline is Friday, June 6, 2014.

News Byte: MediaCrossing Partners with ASL Marketing on Youth Marketing Tool

News Byte: MediaCrossing Partners with ASL Marketing on ...

The digital media trading firm and marketing database company aim to help marketers target 13 to 34 year olds.